Here's how to tell if your heart is trending towards accelerated aging—and what to do if it is, according to an expert cardiologist.
Background The National Heart Failure Audit gathers data on patients coded at discharge (or death) as having heart failure as ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of KANDLELIT-007, a ...
1) Innovent has positioned itself at the forefront of China’s GLP-1 market with Mazdutide, the first-in-class dual GCG/GLP-1 receptor agonist approved for obesity and overweight in June 2025.
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...